ENTITY
Celltrion

Celltrion (068270 KP)

21
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Refresh
bearishWuxi Biologics
14 Jan 2019 04:16

WuXi Biologics – The Foxconn or Qualcomm of Global CDMO?

During the first week of 2019, we visited Wuxi Biologics (Cayman) Inc (2269 HK) headquarters in Shanghai, as well as spend time touring the lab....

Logo
850 Views
Share
bearishCelltrion Inc
30 Dec 2018 01:35

Celltrion/Celltrion H Pair: Last 2 Days Must Be Price Divergence, Not Mean Reversion

The accounting fraud issue had hammered the Celltrion duo nearly equally up until Dec 26. But last two days were different. Healthcare got hurt...

Logo
754 Views
Share
26 Dec 2018 07:42

Korean Stock Market Sectors 2018 Review & 2019 Outlook

In this report, we review the major sectors' performance in the Korean stock market in 2018 and also provide our outlook for them in 2019. We...

Logo
951 Views
Share
16 Dec 2018 07:46

Last Week in Event SPACE: ANTA, Japan Display, Pioneer, Naspers, Huatai, Red Hat

 Last Week in Event SPACE ... The reward/risk is pretty decent on the Anta Sports Products (2020 HK) /Amer Sports Oyj (AMEAS FH) trade. A rumoured...

Logo
523 Views
Share
bearishCelltrion Inc
13 Dec 2018 10:06

Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare

I initiated a pair trade (short Celltrion / long Healthcare) on Oct 22. Yield peaked at 16.66% on Nov 22. It now stays at 8.75%. The ongoing FSS...

Logo
548 Views
Share
x